CIK: 1791159 - Address: C/O Oyster Point Pharma, Inc., 202 Carnegie Center, Suite 106, Princeton, NJ 08540
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/22/21 16:41
10/21/21
OYSTOyster Point Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagNau JeffreyNJDOP,CEOM.d511.0205081112D
9/1/21 18:00
9/1/21
OYSTOyster Point Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagNau JeffreyNJDOP,CEOM.d101.020101962D
4/2/21 14:11
4/2/21
OYSTOyster Point Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagNau JeffreyNJDOP,CEOM.d101.020102452D
2/23/21 20:13
2/19/21
OYSTOyster Point Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagNau JeffreyNJDOP,CEOM.d101.020103142D
7/30/20 19:37
7/28/20
OYSTOyster Point Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagNau JeffreyNJDOP,CEOM.d51.02055006D
11/5/19 06:05
11/4/19
OYSTOyster Point Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagNau JeffreyNJDOP,CEOP1616.0001New1I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact